Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis
- PMID: 35704267
- DOI: 10.1007/s12072-022-10353-4
Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis
Abstract
Purpose: To analyze the long-term oncological outcomes of Barcelona Clinic Liver Cancer (BCLC) stages 0-A hepatocellular carcinoma (HCC) patients associated with or without microvascular invasion (MVI) treated with laparoscopic versus laparotomic liver resection.
Methods: Clinicopathological data of HCC patients with BCLC stages 0-A from four medical centers were retrospectively reviewed. The survival outcomes of patients who underwent laparoscopic hepatectomy were compared with those who underwent laparotomic hepatectomy. Subgroup analyses in terms of MVI were further performed to explore the effect of surgical approaches on the long-term survival outcomes. Propensity score matching (PSM) analysis was used to match patients between the laparoscopic and laparotomic resection groups in a 1:1 ratio.
Results: 495 HCC patients at BCLC stages 0-A were enrolled, including 243 in the laparoscopic resection group and 252 in the laparotomic resection group. Laparoscopic resection group had a shorter operation time, less blood loss, a lower frequency of blood transfusion and postoperative complication rates. The laparoscopic resection group had a significantly better overall survival (OS) and recurrence-free survival (RFS) than the laparotomic resection group before and after PSM. Subgroup analysis demonstrated that OS and RFS of patients without MVI were remarkably better in the laparoscopic resection group compared with the laparotomic resection group. However, no significant differences in OS and RFS between the two groups were found in patients with MVI after PSM.
Conclusions: Pure laparoscopic hepatectomy for patients with BCLC stages 0-A HCC can be performed safely with favorable perioperative and long-term oncological outcomes at high-volume liver cancer centers, regardless of the presence of MVI.
Keywords: Barcelona Clinic Liver Cancer; Hepatocellular carcinoma; Laparoscopic; Laparotomic; Liver resection; Microvascular invasion; Perioperative outcomes; Propensity score matching; Survival outcomes.
© 2022. Asian Pacific Association for the Study of the Liver.
Comment in
-
Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues.Hepatol Int. 2022 Oct;16(5):1250-1251. doi: 10.1007/s12072-022-10413-9. Epub 2022 Aug 25. Hepatol Int. 2022. PMID: 36002715 No abstract available.
-
Response to: "Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues".Hepatol Int. 2023 Oct;17(5):1322-1323. doi: 10.1007/s12072-023-10485-1. Epub 2023 Mar 4. Hepatol Int. 2023. PMID: 36871099 No abstract available.
Similar articles
-
Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study.Hepatol Int. 2023 Oct;17(5):1251-1264. doi: 10.1007/s12072-023-10492-2. Epub 2023 Apr 15. Hepatol Int. 2023. PMID: 37060489
-
The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.BMC Cancer. 2018 Mar 12;18(1):278. doi: 10.1186/s12885-018-4196-x. BMC Cancer. 2018. PMID: 29530006 Free PMC article.
-
Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.Surg Endosc. 2024 Feb;38(2):799-812. doi: 10.1007/s00464-023-10589-7. Epub 2023 Dec 7. Surg Endosc. 2024. PMID: 38062182
-
Survival effects of postoperative adjuvant TACE in early-HCC patients with microvascular invasion: A multicenter propensity score matching.J Cancer. 2024 Jan 1;15(1):68-78. doi: 10.7150/jca.87435. eCollection 2024. J Cancer. 2024. PMID: 38164269 Free PMC article. Review.
-
Laparoscopic versus open repeat hepatectomy for recurrent hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched cohort studies.Int J Surg. 2023 Apr 1;109(4):963-971. doi: 10.1097/JS9.0000000000000305. Int J Surg. 2023. PMID: 36999779 Free PMC article.
Cited by
-
A deep learning-based psi CT network effectively predicts early recurrence after hepatectomy in HCC patients.Abdom Radiol (NY). 2025 Sep;50(9):4076-4086. doi: 10.1007/s00261-025-04849-4. Epub 2025 Feb 26. Abdom Radiol (NY). 2025. PMID: 40009155
-
Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study.J Cancer Res Clin Oncol. 2024 Oct 5;150(10):445. doi: 10.1007/s00432-024-05979-w. J Cancer Res Clin Oncol. 2024. PMID: 39367929 Free PMC article.
-
A systematic review and meta-analysis of blood transfusion rates during liver resection by country.Ann Surg Treat Res. 2023 Dec;105(6):404-416. doi: 10.4174/astr.2023.105.6.404. Epub 2023 Nov 29. Ann Surg Treat Res. 2023. PMID: 38076606 Free PMC article.
-
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):246-266. doi: 10.21037/hbsn-24-359. Epub 2024 Dec 30. Hepatobiliary Surg Nutr. 2025. PMID: 40342785 Free PMC article. Review.
-
Response to: "Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues".Hepatol Int. 2023 Oct;17(5):1322-1323. doi: 10.1007/s12072-023-10485-1. Epub 2023 Mar 4. Hepatol Int. 2023. PMID: 36871099 No abstract available.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249 - DOI
-
- Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, et al. Nomogram for preoperative estimation of microvascular invasion risk in Hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg. 2016;151:356–363 - DOI
-
- European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236 - DOI
-
- Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv238–iv255 - DOI
-
- Han HS, Shehta A, Ahn S, Yoon YS, Cho JY, Choi Y. Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching. J Hepatol. 2015;63:643–650 - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous